Sam Brusco, Associate Editor02.06.24
Globus Medical has promoted CFO Keith Pfeil to chief operating officer (COO).
Pfeil has been the company’s CFO since August 2019. Globus hopes his new, expanded role will drive its strategic roadmap via business and operational planning, as well as managing financial performance. Before Globus, Pfeil spent over 15 years at consumer products company CSS Industries.
He will continue to report to Globus president and CEO Dan Scavilla.
"I am excited to take on the role of COO in addition to my current role of CFO, as Globus continues to build on the momentum we have created to transform our industry and help change more patient lives around the globe," said Pfeil. "I look forward to continuing to work with our board of directors, Dan and the executive leadership team to further realize our growth potential."
Pfeil’s promotion comes on the heels of Globus completing its merger with NuVasive.
"With a track record of over 20 years of high-performance industry experience, including the past four years with Globus, Keith has demonstrated operational and financial leadership and a deep passion for our business," said Scavilla. "I am confident he will help us continue to unlock operational efficiency, deliver the next phase of profitable growth, and ensure a successful transition through our ongoing integration following our merger with NuVasive, which continues to progress according to plan."
Globus expects to share Q4 and full-year 2023 results on February 20.
Pfeil has been the company’s CFO since August 2019. Globus hopes his new, expanded role will drive its strategic roadmap via business and operational planning, as well as managing financial performance. Before Globus, Pfeil spent over 15 years at consumer products company CSS Industries.
He will continue to report to Globus president and CEO Dan Scavilla.
"I am excited to take on the role of COO in addition to my current role of CFO, as Globus continues to build on the momentum we have created to transform our industry and help change more patient lives around the globe," said Pfeil. "I look forward to continuing to work with our board of directors, Dan and the executive leadership team to further realize our growth potential."
Pfeil’s promotion comes on the heels of Globus completing its merger with NuVasive.
"With a track record of over 20 years of high-performance industry experience, including the past four years with Globus, Keith has demonstrated operational and financial leadership and a deep passion for our business," said Scavilla. "I am confident he will help us continue to unlock operational efficiency, deliver the next phase of profitable growth, and ensure a successful transition through our ongoing integration following our merger with NuVasive, which continues to progress according to plan."
Globus expects to share Q4 and full-year 2023 results on February 20.